Westchester Capital Management (New York)’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Westchester Capital Management (New York)’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-302,939	Closed	-$3M	–	446
2021 Q4	$3M	Buy	302,939 +4	+0%	+$40	0.09%	168
2021 Q3	$3M	Buy	+302,935	New	+$2.97M	0.09%	137

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

CGC

Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCMH

Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

Westchester Capital Management (New York)'s GRNA Position: Q1 2022 in Review

Westchester Capital Management (New York) sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2022, closing a stake of 302,939 shares — an estimated $3M sold.

Westchester Capital Management (New York) first reported a position in GRNA in Q3 2021 and held it in 2 quarters. The position peaked at $3M in Q4 2021. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

Westchester Capital Management (New York) reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 302,939 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2022, an estimated $3M.
Westchester Capital Management (New York) first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2021 and held it in 2 quarters.
Westchester Capital Management (New York)'s GreenLight Biosciences Holdings, PBC Common Stock position peaked at $3M in Q4 2021.
39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2022, filed 16 May 2022.